RxDoctor Payments Data

Sheldon Miller, DPM

Podiatrist · Rockaway Park, NYNPI 1932280856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 580 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,826, 2.8 times the $1,006 reported in 2019. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,199in general payments, 2019–2025

Across 580 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$1K
  • Neurocrine Biosciences, Inc.$1K
  • UCB, Inc.$1K
  • Lundbeck LLC$709
  • Amgen$700
  • ANI Pharmaceuticals, Inc.$577
  • plus $6K from 39 others

What the payments were for

  • Speaking & faculty fees$550%
  • Food & beverage$12,13799%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,199 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$50,391
Medicare patients
139
Services billed
688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Rockaway Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →